MEI Pharma Encouragea Shareholders Not To Be Confused By Anson And Cable Car's Latest Press Release
Portfolio Pulse from Benzinga Newsdesk
MEI Pharma has urged its shareholders not to be swayed by the latest press release from Anson and Cable Car. The company's board continues to support the pending transaction with Infinity.
June 27, 2023 | 9:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MEI Pharma's board remains committed to the Infinity transaction despite Anson and Cable Car's press release. This could potentially cause volatility in MEIP's stock price.
The news directly involves MEI Pharma and its pending transaction with Infinity. The company's response to Anson and Cable Car's press release indicates a potential for conflict, which could lead to volatility in the stock price. However, the ultimate impact will depend on the shareholders' reaction and the outcome of the Infinity deal.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100